Thiazolidinediones (TZDs). These drugs help insulin to work better in muscle and fat and also reduces glucose production in the liver. TZDs can
by BY Kim 2024 Cited by 7Lobeglitazone (trade name, Duvie, Chong Kun Dang Pharmaceutical Corporation, Seoul, Korea) is a novel thiazolidinedione (TZD). TZD-based drugs
Thiazolidinediones (TZDs) are anti-diabetic drugs that act as insulin sensitizers and are used in the management of type 2 diabetes mellitus. TZDs, which
by YW Wen 2024 Cited by 11Conclusions: Medical centers began to prescribe TZDs earlier, and they prescribed more TZDs at a faster pace. The TZD diffusion patterns varied among hospitals
by W Wang Cited by 38Subgroup analysis showed that, when compared with placebo or no additional drugs, TZDs TZD-treated patients using quantitative methods. However, our
Although TZDs are not currently in clinical use as anti-inflammatory drugs, more recent observations were done to show that TZDs act as anti-inflammatory
Mild anemia: TZDs higher risk than other drugs. (absolute risk difference 1 TZD use vs no drugs. To evaluate the impact of several classes of oral.
by M Adil 2024 Cited by 3Conclusions. TZDs associated with risk of fracture in T2DM patients. From NMA, TZDs seems least effective drug for the T2DM patients with fracture risk. The
by S Crunkhorn 2024 Cited by 3Thiazolidinediones (TZDs) are the major drug class used to improve insulin sensitivity in the treatment of type 2 diabetes. However, TZDs have several
Comments